LivaNova is a medical device company focused on the development and delivery of therapeutic solutions for the benefit of patients, healthcare personnel and healthcare systems. Co.'s principal business franchises, which are also its reportable segments are: Cardiovascular and Neuromodulation. Co.'s cardiovascular business franchise is engaged in the development, production and sale of cardiopulmonary products, heart valves and advanced circulatory support products. Co.'s neuromodulation business franchise designs, develops and markets neuromodulation-based medical devices for the treatment of epilepsy, depression and obstructive sleep apnea. The LIVN stock yearly return is shown above.
The yearly return on the LIVN stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2019 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the LIVN annual return calculation with any dividends reinvested as applicable (on ex-dates).
|